Get started
Author

Todd Butler

Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
2006 · Michael A. Kamm, William J. Sandborn, et al. · Gastroenterology · 352
Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis
2007 · Gary R. Lichtenstein, Michael A. Kamm, et al. · Clinical Gastroenterology and Hepatology · 267
MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild‐to‐moderate ulcerative colitis: a combined analysis of two randomized, double‐blind, placebo‐controlled trials
2007 · W. J. SANDBORN, M. A. KAMM, et al. · Alimentary Pharmacology & Therapeutics · 168
Plasma levels of B-lymphocyte stimulator increase with HIV disease progression
2003 · Benigno Rodriguez, Hernan Valdez, et al. · AIDS · 50
Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers
2018 · Ofir Moreno, Todd Butler, et al. · Clinical Therapeutics · 28
PDF
Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
2015 · Guillermo Garcia-Manero, Ehab Atallah, et al. · Blood · 25
MMX Mesalamine for Maintaining Remission of Ulcerative Colitis (UC)
2006 · Gary R. Lichtenstein, Todd Butler, et al. · The American Journal of Gastroenterology · 1
ME‐401, A NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3‐KINASE P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B‐CELL LYMPHOID MALIGNANCIES
2017 · R.G. Ghalie, J.M. Pagel, et al. · Hematological Oncology
PDF
Therapeutic advances and issues of patient adherence in the treatment of ulcerative colitis
2007 · Edward V. Loftus, S P Kane, et al. · Gastroenterología y Hepatología
Works count: 9
Citation count: 891
H-index: 6
I10-index: 6
Year
Topic
Type